Evidence map›Paper›PMID 40193027›Full record

ArticleHelicobacter

Real-Time PCR Helicobacter pylori Test in Comparison With Culture and Histology for Helicobacter pylori Detection and Identification of Resistance to Clarithromycin: A Single-Center Real-Life Study.

Kateryna Priadko, Sophie-Anne Gibaud, Amaury Druet, Louise Galmiche, Francis Megraud, Stéphane Corvec, Tamara Matysiak-Budnik

Abstract readComparative Study
In one paragraph

Article in Helicobacter. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Resistance to Clarithromycin and Fluoroquinolones inAntibiotics (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kateryna PriadkoNantes Université, CHU Nantes, IMAD, Hepato-Gastroenterology & Digestive Oncology, Nantes, France.ORCID https://orcid.org/0000-0003-3551-1006
Sophie-Anne GibaudDepartment of Bacteriology and Microbiological Control, University Hospital of Nantes, Nantes, France.
Amaury DruetNantes Université, CHU Nantes, IMAD, Hepato-Gastroenterology & Digestive Oncology, Nantes, France.
Louise GalmicheDepartment of Pathology, University Hospital of Nantes, Nantes, France.
Francis MegraudINSERM U1312 BRIC, University of Bordeaux, Bordeaux, France.
Stéphane CorvecDepartment of Bacteriology and Microbiological Control, University Hospital of Nantes, Nantes, France.
Tamara Matysiak-BudnikNantes Université, CHU Nantes, IMAD, Hepato-Gastroenterology & Digestive Oncology, Nantes, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn our center, RT-PCR was integrated as a routine method to diagnose Helicobacter pylori due to its higher availability after COVID-19 pandemics. The objective of this study was to assess the feasibility and performance of systematically performed RT-PCR for H. pylori detection and clarithromycin (CLA) resistance in a real-life clinical practice. MATERIALS AND

methodsOne hundred consecutive patients underwent an upper digestive endoscopy during which at least four biopsies (two from the antrum and two from the corpus) were obtained for RT-PCR and culture with antibiogram and four additional biopsies for histology. The results of H. pylori detection were compared among RT-PCR, histology, and bacterial culture, and the results of CLA susceptibility were compared between culture-based antibiogram and RT-PCR.

resultsOut of 100 patients, 64 were positive for H. pylori by RT-PCR, 66 by histology, and 53 by culture, with no statistically significant difference among the three methods (p > 0.05). CLA resistance was found in 8 out of 45 patients (17.7%) by culture and in 12 out of 64 patients (18.7%) by PCR. In 8 H. pylori-positive patients by culture, the antibiogram could not be realized due to lack of viability of the strains. In one patient, after a double checking, discrepant results were observed, requiring a complementary molecular analysis by the French National Reference Center for Helicobacters, which confirmed the existence of a double population of H. pylori strains within biopsies, with and without CLA resistance.

conclusionsOur study demonstrates that in real-life clinical practice, RT-PCR is feasible and comparable in the ability to detect H. pylori and its resistance to CLA to bacterial culture with antibiogram and histology. Given its rapidity and limited dependence on the operator's interpretation, it appears preferable to the other methods.

Indexed as

Anti-Bacterial AgentsClarithromycinDrug Resistance, BacterialHelicobacter InfectionsHelicobacter pyloriReal-Time Polymerase Chain ReactionAdultAgedAged, 80 and overBiopsyCOVID-19FemaleHumansMaleMicrobial Sensitivity TestsMiddle AgedAnti-Bacterial AgentsClarithromycinclarithromycin resistanceculturegastritisHelicobacter pylorihistologyRT‐PCR

Identifiers

PMID40193027
PMCPMC11975209

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.